Drug Profile
Research programme: rheumatoid arthritis antibody therapies - Debiopharm
Alternative Names: Anti-CD44vRA antibody; Debio-0618Latest Information Update: 12 Aug 2010
Price :
$50
*
At a glance
- Originator Debiopharm
- Class Antibodies
- Mechanism of Action CD44 antigen inhibitors; Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Rheumatoid arthritis
Most Recent Events
- 12 Jun 2007 Preclinical trials in Rheumatoid arthritis in Switzerland (Parenteral)